Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon

International Journal of Colorectal Disease

Volumn 18, Issue 1, 2003, Pages 55-62

  Latella, Giovanni ^a   Pimpo, Maria Teresa ^a   Sottili, Sandra ^b   Zippi, Maddalena ^c   Viscido, Angelo ^c   Chiaramonte, Maria ^a   Frieri, Giuseppe ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Antibiotics; Dietary fiber; Diverticular disease; Glucomannan; Rifaximin

Indexed keywords

ANTIBIOTIC AGENT; MANNAN; RIFAXIMIN;

ABDOMINAL DISEASE; ABDOMINAL PAIN; ADULT; AGED; ARTICLE; ASTHENIA; CLINICAL TRIAL; COLON DIVERTICULOSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIET SUPPLEMENTATION; DIETARY FIBER; DIVERTICULITIS; DRUG ABSORPTION; DRUG EFFICACY; FEMALE; HEADACHE; HUMAN; INCIDENCE; MALE; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECTUM HEMORRHAGE; SCORING SYSTEM; SYMPTOMATOLOGY;

ADULT; AGED; AGED, 80 AND OVER; CATHARTICS; DIVERTICULUM, COLON; DRUG EVALUATION; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL AGENTS; HUMANS; ITALY; MALE; MANNANS; MIDDLE AGED; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; RIFAMYCINS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 0037804072     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-002-0396-5     Document Type: Article

References (50)

1. Parks TG (1975) Natural history of diverticular disease of the colon. Clin Gastroenterol 4:53-69
2. Almy TP, Howell DA (1980) Diverticular disease of the colon. N Engl J Med 302:324-331
3. Walters DAK, Smith AN (1990) Strength of the colon wall in diverticular disease. Br J Surg 77:257-259
4. Roberts PI, Weidenheimer MC (1990) Diverticular disease of the colon. In: Bayless TM (ed) Current therapy in gastroenterology and liver diseases. Decker, Philadelphia, pp 416-419
5. Ferzoco LB, Raptopoulos V, Silen W (1998) Acute diverticulitis. N Engl J Med 338:1521-1526
6. Kohler L, Sauerland S, Neugebauer E, for the Scientific Committee of the European Association for Endoscopic Surgery (EAES) (1999) Diagnosis and treatment of diverticular disease. Results of a consensus development conference. Surg Endosc 13:430-436
7. Schwartz JT, Graham DY (1988) Diverticular disease of the large intestine. In: Kirsner J, Shorter R (eds) Diseases of the colon, rectum and anal canal. Williams & Wilkins, Baltimore, pp 519-536
8. Naitove A, Smith RE (1993) Diverticular disease of the colon. In: Sleisenger MH, Fordtran TS (eds) Gastrointestinal disease, 5th edn. Saunders, Philadelphia, pp 1347-1363
9. Fleischner FG, Ming SC (1965) Revised concepts on diverticular disease of the colon. II. So-called diverticulitis: diverticular sigmoiditis and perisigmoiditis, diverticular abscess, fistula, and frank peritonitis. Radiology 84:599-609
10. Painter NS, Burkitt DP (1971) Diverticular disease of the colon: a deficiency disease of western civilization. BMJ 2:450-454
11. Painter NS, Burkitt DP (1974) Diverticular disease of the colon: a 20th century problem. J Clin Gastroenterol 4:3-21
12. Hodgson WJB (1972) An interim report on the production of colonic diverticula in the rabit. Gut 13:802-804
13. Fisher N, Berry CS, Feam T, et al (1985) Cereal dietary fiber consumption and diverticular disease: a lispam study in rats. Am J Clin Nutr 42:788-804
14. Brodribb AJM, Humphreys DM (1976) Diverticular disease: three studies. I. Relation to other disorders and fibre intake. BMJ 1:424-430
15. Gear JSS, Ware A, Fursdon P, et al (1979) Symptomless diverticular disease and intake of dietary fiber. Lancet I:511-514
16. Manousos O, Day NE, Tzonou A, et al (1985) Diet and other factors in the aetiology of diverticulosis: an epidemiological study in Greece. Gut 26:544-549
17. Aldoori WH, Giovannucci EL, Rimm EB, et al (1994) A prospective study of diet and the risk of symptomatic diverticular disease in men. Am J Clin Nutr 60:757-764
18. Aldoori WH, Giovannucci EL, Rockett HRH, et al (1998) A prospective study of dietary fiber types and symptomatic diverticular disease in men. J Nutr 128:714-719
19. Brodribb AJM (1977) Treatment of symptomatic diverticular disease with high-fibre diet. Lancet I:664-666
20. Weinreich J (1982) The treatment of diverticular disease. Scand J Gastroenterol Suppl 79:128-129
21. Ewerth S, Ahlberg J, Holmstrom B, et al (1990) Influence on symptoms and transit time of Vi Siblin R in diverticular disease. Acta Chir Scand Suppl 500:40-59
22. Davey WW (1968) Diet and diverticulosis. BMJ 1:118-120
23. Archampong EQ, Christian F, Badoe EA (1978) Diverticular disease in an indigenous African community. Ann R Coll Surg Engl 60:464-470
24. Ornestein MH, Littlewood ER, Baird IM, et al (1981) Are fibre supplements really necessary in diverticular disease of the colon? A controlled clinical trial. BMJ 282:1353-1356
25. Hodgson WJB (1977) The placebo effect: is it important in diverticular disease? Am J Gastroenterol 67:157-162
26. Mendeloff AI (1976) A critique of "fibre deficiency." Am J Dig Dis 21:109-112
27. Torsoli A, Inoue M, Manousos O, et al (1991) Diverticular disease of the colon. Data relevant to treatment. Gastroenterol Int 4:3-20
28. Schechter S, Mulvey J, Eisenstat TE (1999) Management of uncomplicated acute diverticulitis. Results of a survey. Dis Colon Rectum 42:470-476
29. Papi C, Ciaco A, Koch M, Capurso L, Diverticular Disease Study Group (1992) Efficacy of rifaximin on symptoms of uncomplicated diverticular disease of the colon. A pilot multicentre open trial. Ital J Gastroenterol 24:452-456
30. Papi C, Ciaco A, Koch M, Capurso L (1995) Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double-blind placebo-controlled trial. Aliment Pharmacol Ther 9:33-39
31. Kurpad AV, Shetty PS (1986) Effects of antimicrobial therapy on faecal bulking. Gut 27:55-58
32. Casagrande JT, Pike MC (1978) An improved approximate formula far calculating sample sizes for comparing two binomial distributions. Biometrics 34:483-486
33. Armitage P, Berry G (1994) Statistical methods in medical research. Blackwell Scientific Publication Limited, Oxford
34. Doi K, Matsuura M, Kawara A, et al (1979) Treatment of diabetes with glucomannan (Konjac mannan). Lancet I:987-988
35. Cucchiara S, Devizia B, Staiano A, et al (1989) Trattamento della stipsi cronica funzionale del bambino con somministrazione di fibre vegetali. Minerva Pediatr 41:147-152
36. Marzio L, Del Biamco R, Delle Donne MD, et al (1989) Mouth-to-cecum transit time in patients affected by chronic constipation: effect of glucomannan. Am J Gastroenterol 84:888-891
37. Passaretti S, Franzoni M, Comin U, et al (1991) Action of glucomannan on complaints in patients affected with chronic constipation: a multicentric clinical evaluation. Ital J Gastroenterol 23:421-425
38. Painter NS (1974) The high fibre diet in the treatment of diverticular disease of the colon. Postgrad Med J 50:629-635
39. Burkit DP (1975) Dietary fibre and "pressure disease." J R Coll Physicians (Lond) 9:138-147
40. Eastwood MA (1975) Medical and dietary management. J Clin Gastroenterol 4:85-97
41. Brodribb AJM, Humphreys DM (1976) Diverticular disease: three studies. II. Treatment with bran. BMJ 1:425-428
42. Findlay JM, Smith AN, Mitchell WD, et al (1974) Effects of unprocessed bran on colon function in normal subjects and in diverticular disease. Lancet I:146-149
43. Srivastava GS, Smith AN, Painter NS (1976) Sterculia bulk-forming agent with smooth-muscle relaxant versus bran in diverticular disease. BMJ 1:315-318
44. Painter NS (1968) Diverticular disease of the colon. BMJ 3:475-479
45. Arfwidsson S, Dock NG (1964) Pathogenesis of multiple diverticula of the sigmoid colon in diverticular disease. Acta Chir Scand Suppl 342:1-68
46. Weinreich J, Anderson D (1976) Intraluminal pressure in the sigmoid colon. II. Patients with sigmoid diverticula and related conditions. Scand J Gastroenterol 11:581-586
47. Ritchie L (1977) Similarity of bowel distension characteristics in the irritable bowel syndrome and diverticulosis (abstract). Gut 18:A990
48. Gillis JC, Brogden RN (1995) Rifaximin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential in conditions mediated by gastrointestinal bacteria. Drugs 49:467-484
49. Stephen AM, Cummings IH (1980) Mechanisms of action of dietary fibre in the human colon. Nature 284:183-184
50. Toskes PP, Donalson RM (1993) Enteric bacterial flora and bacterial overgrowth syndrome. In: Sleisenger MH, Fordtran TS (eds) Gastrointestinal disease, 5th edn. Saunders, Philadelphia, pp 1106-1117